The European Medicines Agency has started a review of medicines containing finasteride and dutasteride following concerns ...

In today’s fast-paced world, maintaining optimal health is paramount, especially for men who may face unique health ...

Some facial bumps that appear in clusters may not be acne but could indicate something more serious, requiring your care and ...

In 2019, there were 94 million cases of benign prostatic hyperplasia (BPH) worldwide. Our systematic review evaluated the effectiveness of Urtica dioica (Stinging Nettle) as a treatment of benign ...

Financial writer advises caution on Jyong Biotech Ltd. IPO due to high debt, legal issues, and FDA challenges. Click for my ...

Despite the recent launch of congenital adrenal hyperplasia (CAH) drug Crenessity, Neurocrine Biosciences' disappointing ...

A physician, Dr. Sam Adegboye, has debunked the claim that frequent sexual activity reduces the risk of prostate cancer in men. Adegboye is the Assistant Chief Medical Officer and General Practitioner ...

By Temitope PonleDr Sam Adegboye, a Physician, has debunked the claim that frequent sexual activity reduces the risk of prostate cancer in men.Adegboye is the Assistant Chief Medical Officer and ...

Cancer Prevention Research publishes articles that focus on cancer prevention, preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis ...

For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology ...

CFO Matt Abernethy projected INGREZZA sales for 2025 to range between $2.5 billion and $2.6 billion, reflecting $250 million growth at the midpoint. He noted increased competitive pressure and payer ...